Article
Pegylated interferon-α induced hypoferremia is associated with the immediate response to treatment in hepatitis C.
Hepatology (Baltimore, Md.) - 1 Aug 2012
Ryan John D, Altamura Sandro, Devitt Emma, Mullins Sarah, Lawless Matthew W, Muckenthaler Martina U, Crowe John
Abstract excerpt
UNLABELLED: Pegylated interferon-α (PEG-IFN-α) forms an integral part of the current treatment for hepatitis C virus (HCV) infection. PEG-IFN-α suppresses HCV production by augmenting the innate antiviral immune response. Recent studies have reported the induction of hepcidin, the iron regulatory hormone, by IFN-α in vitro. As hepcidin plays an important role in innate immunity, we hypothesized that this finding...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
